Showing 1-10 of about 203 articles.
Praxis Precision Medicines, Inc
FDA grants RPD and ODD for PRAX-222 for treatment of SCN2A-DEE FDA grants RPD for PRAX-562 for treatment of SCN2A-DEE and SCN8A-DEE CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Praxis...
Saniona AB
PRESSMEDDELANDE 7 januari 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att Rami Levin, Sanionas koncernchef och VD,...
Saniona AB
PRESS RELEASE January 7, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that Rami Levin, President and Chief Executive Officer of...
Inozyme Pharma Inc.
– U.S. Food and Drug Administration cleared Investigational New Drug Application – – United Kingdom Medicines and Healthcare Products Regulatory Agency authorized Clinical Trial Application – –...
Saniona AB
PRESS RELEASE December 21, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the further expansion of its executive team with the...
Saniona AB
PRESSMEDDELANDE 21 december 2020 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att ledningsgruppen utökas ytterligare...
Saniona AB
PRESSMEDDELANDE 16 december 2020 Saniona minskar sin ägarandel i Scandion Oncology till under 5 procent som ett resultat av Scandions framgångsrika företrädesemission Saniona (OMX: SANION), ett...
Saniona AB
PRESS RELEASE December 16, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the reduction of its ownership stake in Scandion Oncology...
Travere Therapeutics, Inc.
SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced completion of patient enrollment in the Phase 3 DUPLEX Study. The pivotal DUPLEX Study is evaluating...
Saniona AB
PRESSMEDDELANDE 30 november 2020 Finansiella nyckeltal Jan - sep 2020 (jan - sep 2019) Nettoomsättningen uppgick till 4,6 MSEK (2,7)EBIT uppgick till -97,0 MSEK (-75,8)Periodens...
Showing 1-10 of about 203 articles.
